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Pathogens induce severe damages on cultivated plants and represent a serious threat to global food
security. Emerging strategies for crop protection involve the external treatment of plants with
double-stranded (ds)RNA to trigger RNA interference. However, applying this technology in
greenhouses and fields depends on dsRNA quality, stability and efficient large-scale production.
Using components of the bacteriophage phi6, we engineered a stable and accurate in vivo dsRNA
production system in Pseudomonas syringae bacteria. Unlike other in vitro or in vivo dsRNA
production systems that rely on DNA transcription and postsynthetic alignment of single-stranded
RNA molecules, the phi6 system is based on the replication of dsRNA by an RNA-dependent RNA
polymerase, thus allowing production of high-quality, long dsRNAmolecules. The phi6 replication
complex was reprogrammed to multiply dsRNA sequences homologous to tobacco mosaic virus
(TMV) by replacing the coding regions within two of the three phi6 genome segments with TMV
sequences and introduction of these constructs into P. syringae together with the third phi6
segment,which encodes the components of the phi6 replication complex. The stable production of
TMV dsRNA was achieved by combining all the three phi6 genome segments and by maintaining
the natural dsRNA sizes and sequence elements required for efficient replication and packaging of
the segments. The produced TMV-derived dsRNAs inhibited TMV propagation when applied to
infected Nicotiana benthamiana plants. The established dsRNA production system enables the
broad application of dsRNA molecules as an efficient, highly flexible, nontransgenic and
environmentally friendly approach for protecting crops against viruses and other pathogens.
Introduction
Agricultural yields are greatly affected by various pathogens and
pests which decrease production of crops worldwide (Oerke,
2005) with losses adding up to around $US100 billion per year
(Fletcher et al., 2006) and potentially reaching U$540 billion per
year if the spreading of invasive pests and pathogens is not
controlled (Kew Royal Botanical Gardens, 2017; Paini et al.,
2016). To protect plants against pathogens and pests, agriculture
relies on the widespread use of chemical pesticides that are
applied to the environment in large amounts. These intense
applications of chemical pesticides pose potential risks of human
health, beneficial organisms and the environment (Nicolopoulou-
Stamati et al., 2016). Thus, there is a need for novel tools and
alternative methods to control disease epidemics. Indeed, legis-
lation in Europe is aiming at reducing the use of chemical plant
protection products and calling for an in-depth reconsideration of
crop protection solutions (Union, 2009). A promising new
approach with strong potential for protecting plants against
viruses and other pathogens involves the application of double-
stranded (ds)RNA.
dsRNA is a natural product that occurs in most, if not all,
organisms in nature. It triggers RNA silencing, also known as RNA
interference (RNAi), which is a conserved eukaryotic mechanism
playing a crucial role in growth, development, host defence against
viruses and transposon inactivation, across plant, fungi and animal
kingdoms. RNAi plays a natural role in antiviral defence by targeting
the invading viral RNA genomes and viral transcripts for cleavage
and translational repression in a sequence-specific manner (Ding,
2010; Pumplin and Voinnet, 2013). Consistentwith the central role
of dsRNA in triggering RNAi, numerous studies have shown that
plants treated with virus-specific dsRNA or single-stranded RNA
(ssRNA) molecules that fold into hairpin conformation showed
antiviral resistance (Carbonell et al., 2008; Gan et al., 2010;
Konakalla et al., 2016; Tenllado and Diaz-Ruiz, 2001; Tenllado
et al., 2003a,b; Yin et al., 2009). dsRNAs were also shown to be
effective against fungi (Koch et al., 2016;Wang et al., 2016, 2017)
and insects (Baum et al., 2007; Ghosh et al., 2017; Li et al., 2013;
Luo et al., 2017), thus providing important implications for dsRNA-
triggered RNAi as an emerging novel approach for crop protection.
RNAi has been deployed for plant protection since it was discov-
ered.Aplethora of studies has demonstrated the feasibility of RNAi-
based approaches, and numerous virus-resistant crops have been
approved for commercial release (Khalid et al., 2017). However,
unlike these previous approaches, which depend on transgenes,
the external application of dsRNA will realize crop protection
without anymodification of the plant genome and, therefore, may
be regulated differently compared to crop protection involving
geneticallymodifiedorganisms.Moreover, in being independent of
any time-consuming genetic modification, the application of
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dsRNA is much more flexible and allows faster actions against new
emerging diseases.
Applying dsRNAmay have numerous advantages over the use of
chemical compounds. Unlike chemical compounds, which act via a
structure-dependent mechanism, dsRNAs act by means of their
specific nucleotide sequence. Thus, in being designed to act against
a specific pathogen target with homologous sequence, the dsRNA
agent and derived small interfering (si)RNAs are expected to act
only against the anticipated pathogen. As dsRNA activity depends
on plant RNAi pathways that are essential for plant development,
and given that dsRNA molecules are designed to target the
pathogen and not the plant, the occurrence of plant mutations
leading to resistance against dsRNA-triggered RNAi is unlikely.
Moreover, as dsRNAs exert their inhibitory mode of action
throughout their entire sequence length, the evolution of patho-
gen resistance by selection of dsRNA target sequence mutations is
fairly unlikely as well. Importantly, in contrast to chemical
pesticides, dsRNA agents are biocompatible and biodegradable
compounds that are part of nature and occur ubiquitously inside
and outside organisms as well as in food. Like any RNA molecule,
also dsRNA shows low stability in water or soil (Dubelman et al.,
2014). Within plants and other organisms, dsRNAs enter natural
RNA silencing pathways and are degraded to small RNAs, which
themselves are subject to turnover through natural degradation
mechanisms (Cerutti and Ibrahim, 2010). Thus, RNA sprays will not
produce any substantially novel residues in food products.
However, the broad application of dsRNA treatments in
greenhouses and fields is hampered by the lack of efficient and
economical methods for dsRNA design, large-scale production
and purification. The main approach for producing dsRNAs has so
far been physical annealing of two enzymatically synthesized
ssRNA strands. Annealing is performed either in vitro (Carbonell
et al., 2008; Koch et al., 2016; Konakalla et al., 2016; Tenllado
and Diaz-Ruiz, 2001; Wang et al., 2016) or in vivo following
ssRNA synthesis in RNase III-deficient bacterial cells (Gan et al.,
2010; Tenllado et al., 2003a; Yin et al., 2009). Even though
dsRNA can be produced by these methods, the physical
hybridization of two complementary ssRNA molecules in vitro,
and especially in vivo, often results in relatively low yields of
correctly and fully duplexed dsRNA. Moreover, the bacterial
production systems contain homologous DNA molecules, which
affect the quality of the RNA preparation and its applicability. A
more biological and accurate method to produce dsRNA is to
utilize enzymes encoded by dsRNA viruses that are specialized in
the synthesis of dsRNA. The RNA-dependent RNA polymerase of
the dsRNA phage phi6 (Makeyev and Bamford, 2000) converts
ssRNA templates into dsRNA with high processivity using a de
novo, primer-independent initiation mechanism (Laurila et al.,
2002). In pioneering work, we previously explored the possibility
to use components of phi6 for the in vivo synthesis of dsRNA
aimed for subsequent Dicer digestion and use in animal cell
cultures (Aalto et al., 2007). However, the system proved to be
unstable for the efficient production of most dsRNA molecules.
Here, we report the engineering of a stable and accurate in vivo
dsRNA replication system in bacteria that allows the large-scale
production of long dsRNA molecules targeting pathogen genes or
genomes and suitable for application in crop protection.
Results
For the initial assessment of the effects of dsRNA vaccination on
virus infection, we used target-specific dsRNA molecules that
were produced in vitro using DNA-dependent T7 RNA polymerase
for DNA transcription and the RNA-dependent RNA polymerase
of phi6 for subsequent RNA replication (Figure S1). The dsRNAs
were applied to Nicotiana benthamiana plants infected with a
GFP-tagged tobacco mosaic virus (TMV-GFP) which allows the
in vivo monitoring of infection by the analysis of GFP fluores-
cence. Treating the plants with different in vitro-produced dsRNA
molecules targeting different parts of the viral replicase gene or
the GFP gene inserted in the genome of the TMV-GFP virus led to
efficient inhibition of viral propagation in the treated plants
(Figure 1, Tables S1, and S2). However, producing such efficient
dsRNAs with purified enzymes will not be feasible for large-scale
applications. Thus, to develop this approach further and to
particularly prepare this technology for large-scale applications,
we engineered a phi6-based dsRNA-synthesizing machine within
bacteria.
The genome of phi6 is composed of three dsRNA segments
termed ‘S’ (2948 bp), ‘M’ (4063 bp) and ‘L’ (6374 bp). Upon
infection, the polymerase complex (PC) that forms the internal
layer of the phi6 phage particle is delivered to the cytoplasm of
the host bacterium. The polymerase subunits residing inside the
PC then starts the synthesis of phage ssRNAs using the encap-
sidated genomic dsRNA molecules as templates. These ssRNAs (s,
m and l) are delivered into the cytoplasm whereby the L-segment-
specific ssRNAs direct the synthesis of proteins that self-assemble
into new PCs that are subsequently filled with the ssRNAs. After
completion of the ssRNA packaging, the polymerase subunits
within the PC are activated and synthetize the complementary
strands for each encapsidated ssRNA segment (Figure S2). To
generate specific dsRNA-producing bacteria, we first assembled
an S-segment-specific construct, STMV (Figure 2, Table S3), in
which we incorporated sequences derived from TMV. Assuming
that the size of the phi6 segments may be critical for dsRNA
production, the length of the STMV dsRNA was designed to match
the size of the natural phi6 S-segment. Thus, the TMV-derived
sequence that we inserted between the S-segment-specific
replication and encapsidation signals was 2611 nts in length
and covered parts of the TMV replicase and movement protein
(MP) genes (Figure 2a). To ensure that the ssRNAs initially
transcribed from the plasmid is terminated at the correct length,
a T7 terminator was inserted downstream the STMV construct in
the corresponding plasmid vector (pLD18-5 rep-MP; Figure 2b,c).
However, P. syringae cells transformed with this vector together
with a vector encoding a modified phi6 L-segment carrying a
selectable marker gene (Lkan) failed to stably produce STMV dsRNA
of expected size (3268 bp) (Figure 3a). This failure to produce the
expected dsRNA molecules likely relates to the lack of M-
segment-specific signal sequences that are essential for the
normal regulation of genome packaging and replication by the
phi6 replication complex (Figure S2). Indeed, genetic stability was
achieved when an M-segment-specific construct, MTMV, was
included in the system. Our construct contained a 3540 nts long
insert from the TMV genome (Figure 2a) cloned between the
phi6 M-segment-specific replication and encapsidation signals
(Figure 2b,c). Moreover, similar as for the STMV construct, a T7
terminator sequence was cloned downstream the MTMV construct
(4223 bp) in the corresponding plasmid vector (pMS2-9 rep-MP)
to facilitate the production of correct-length RNA.
Transformation of P. syringae cells with vectors containing the
Lkan, MTMV and STMV constructs led to efficient recovery of
transformed cell lines expressing the expected dsRNA pattern
(7599, 3268 and 4223 bp, respectively; Figure 3b). Moreover, in
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addition to the increased stability, the inclusion of the
M-segment-specific construct substantially increased the amount
of target-specific dsRNA that could be replicated within the phi6
PCs. Our dsRNA preparation, dsRNArep-MP, contained Lkan, STMV
and MTMV dsRNAs in equal ratios and the system produced about
700 lg dsRNArep-MP per 100 ml culture (4 9 109 cells/ml). In
addition to the TMV-specific dsRNA-producing cell lines, we also
generated a control cell line (transformed with plasmids pLM991,
pLM656 and pMH4) that replicates phi6-specific Lkan, M and Slys
dsRNAs (dsRNAphi6) without any foreign inserts except the
selection marker gene (Table S3). Slys is a S-segment that is wild
type except for a mutation that inactivates gene 5 and thereby
Figure 1 Effect of in vitro-produced dsRNAs on the propagation of TMV-GFP and associated disease symptoms in N. benthamiana plants. (a) RNA genome
of TMV-GFP with highlighted protein-coding genes and derived dsRNAs produced in vitro (MP, movement protein; CP, capsid protein). The sequence of
dsRNAGFP4 corresponds to a specific GFP variant, GFP4 (Haseloff et al., 1997) that differs from the virus-encoded GFP (GFPv) by 9% at the nucleic acid
level. (b and c) State of infection at 7 dpi. (b) Inoculated leaves. (c) Whole plants. Single leaves of plants were inoculated with TMV-GFP either alone, or





, dsRNAGFP4 or dsRNAGFPv. Three plants per treatment
are shown. Photographs were taken under ultraviolet (UV) light. Infected leaf areas show green fluorescence and noninfected leaf areas are red fluorescent
(chlorophyll autofluorescence). (d) Symptom phenotypes of treated plants at 14 dpi. Representative images are shown. The individual image panels show
the same healthy noninoculated control plant on the left and the same diseased TMV-GFP infected, H2O-treated control plant on the right. A TMV-GFP
infected and untreated or dsRNA-treated plant is in the middle of each panel as indicated. The experiment was performed two times with three to four
plants per condition.
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prevents the expression of the phi6 lytic functions (Sarin et al.,
2012).
Applying purified in vivo-produced dsRNArep-MP (Lkan, MTMV
and STMV dsRNAs) either mechanically or by spraying to the virus-
inoculated leaves provided efficient protection against local
spread of TMV (Figures 4 and 5). Consistent with the inhibition
of virus spread at the local level, the dsRNA treatment also
reduced the systemic spread of the virus, although to variable
extent (Figure 4). The protective effect of our dsRNA remained
stable for at least 7 days when sprayed onto the leaves
(Figure S3).
Discussion
The in vivo dsRNA production machine we have engineered and
tested here is easily adaptable to different target sequences and,
therefore, has great potential to permit therapeutic dsRNAs to be
designed and produced for large-scale crop protection against
different viral and fungal pathogens, and insect pests. The very
long dsRNA molecules (>2600 base pairs) produced by this system
give rise to a large pool of target-specific siRNAs. The presence of
such a large pool of siRNAs for a single target (i.e. a viral genome)
increases target specificity and, unlike strategies involving single
or few target-specific siRNAs, avoids the evolution of mutations in
the target by which the targeted organism may become resistant
to the treatment. The ability to produce long dsRNAs also offers
the possibility of pyramidic plant protection approaches in
which dsRNAs with sequence homology to multiple and diverse
targets are fused to protect plants against several pathogens
simultaneously.
The major technical obstacle for the utilization of the phi6-
based in vivo dsRNA production system for heterologous dsRNA
production (Aalto et al., 2007) has been the compromised
genetic stability of the cell lines produced. The lack of the
M-segment in the previous design has led to unpredictable
recombination events, instability and repeated failure to produce
the expected dsRNA, similar to that observed when we attempted
to produce cell lines replicating only Lkan and STMV dsRNAs
Figure 2 Design and construction of the phi6 in vivo dsRNA production
platform. (a) Schematic illustration of the RNA genome of TMV and the
areas selected for in vivo dsRNA production. (b) General genetic
components for the construction of a stable in vivo dsRNA production
platform. These originate from (i) the phi6 S, M and L genomic segments,
(ii) T7 bacteriophage, and (iii) target (here: TMV). Optimal sizes of target-
specific sequences, which should be used to produce dsRNA molecules
corresponding to the natural sizes of the S and M genome segments, are
indicated. (c) Construction of the in vivo dsRNArep-MP production platform.
(c, I) Constructs for P. syringae transformation. Lkan encodes the
components of the phi6 polymerase complex (PC), L-segment-specific
RNA replication and packaging signals and the kanamycin resistance gene
nptI. STMV and MTMV contain TMV-specific sequences (without open
reading frames) flanked by phi6 S- or M-segment-specific signal
sequences, respectively. Each construct carries a T7 RNA polymerase
promoter upstream of the segment-specific phi6 packaging signal. (c, II)
Transformation of the plasmids into P. syringae cells, which express T7
RNA polymerase, leads to the transcription of Lkan-, MTMV- and STMV-
specific ssRNA molecules (lkan, mTMV and sTMV). T7 terminators ensure
correct length of the MTMV-, and STMV-specific ssRNA transcripts. (c, III)
Translation of lkan ssRNA (1.) leads to production of empty PCs (2.), which
are sequentially packaged with sTMV, mTMV and lkan ssRNAs (3.). During
packaging, the PC synthesizes the complementary strand for each
packaged ssRNA carrying the phi6-specific RNA replication signal (4.).
Following the first round of dsRNA synthesis, the PCs continue to
synthetize more sTMV, mTMV and lkan ssRNAs (6.), which lead to the
amplification of PCs containing Lkan, MTMV and STMV dsRNAs (dsRNA
rep-MP)
until the host cell is filled with such particles. The plasmids used for the
initial transformation (c, III) do not replicate in P. syringae and are not
present in the cell lines in which dsRNA production is established (III).
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Figure 3 Genetic stability of the dsRNA production cell lines. P. syringae cells were transformed with Lkan construct together with (a) STMV construct,
or (b) STMV and MTMV constructs. Kanamycin-resistant cell lines were selected from each transformation and further cultivated. dsRNA was isolated
from the different bacterial cell cultures and analysed by agarose gel electrophoresis (dsRNAs produced in 10 cell lines are shown). Phi6 genomic
dsRNA composed of the L (6374 bp), M (4063 bp) and S (2948 bp) dsRNA molecules was used as a size marker (left lane). The DNA constructs used
for the transformations are schematically depicted above the gel images. A dsRNA molecule corresponding to the size of the Lkan dsRNA (7599 bp) is
present in all transformants (a and b). However, only few of the cell lines in (a) replicate dsRNA that would correspond the size of STMV (3268 bp). In
contrast, 80% of the cell lines originating from the transformation with Lkan, STMV and MTMV constructs (b) produced expected dsRNA molecules
(7599, 4223 and 3268 bp, respectively).
Figure 4 Effect of in vivo-produced dsRNAs on the local and systemic spread of TMV-GFP in infected N. benthamiana plants. Single leaves of plants
were mechanically inoculated with TMV-GFP together with either H2O, purified dsRNA
phi6 or purified dsRNArep-MP. Four plants per treatment are
shown. Unlike treatment with water or dsRNAphi6, the treatment with dsRNArep-MP inhibits the local and systemic spread of the virus. Photographs
were taken at 14 dpi under UV light. Infected leaf areas show green fluorescence, and noninfected leaf areas are red fluorescent (chlorophyll
autofluorescence).
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(Figure 3A). Based on the current knowledge about the regula-
tion of phi6 dsRNA replication (Figure S2), this challenge was
overcome here (Figure 3B) by including the M-segment and other
essential regulatory elements from the phi6 genome (Figure 2).
Using the M-segment in addition to the S-segment not only
increased stability but also substantially increased the amount of
target-specific dsRNAs produced by the phi6 polymerase complex.
The incorporation of the M-segment into the dsRNA production
system also may facilitate the development of pyramidic plant
protection approaches by producing M- and S-segments that
generate different dsRNAs against different pathogen targets.
P. syringae cell lines harbouring the engineered dsRNA
production of interest can be grown in fermenters, which opens
the way for large-scale vaccination applications to protect plant
crops against a variety of important diseases. Important comple-
mentary new technology has been conceived to enhance the
stability of dsRNA upon spraying and prolonging the time frame
for plant protection to 20 days or more (Mitter et al., 2017).
Therefore, the topical application of dsRNAs has great potential
to become a novel and widespread environmentally friendly
disease management tool that circumvents technical limitations
of plant transformation and the public concerns about genetically
modified organisms.
Experimental procedures
Bacterial strains and viruses
P. syringae strain LM2691 (Sun et al., 2004) was used as a host
for phi6-based dsRNA production. This strain harbours plasmid
pLM1086 (Sun et al., 2004) that constitutively expresses T7 RNA
polymerase. Escherichia coli strain DH5a was used as host for the
production of recombinant plasmids. Virion particles of green
fluorescent protein-tagged TMV (TMV-GFP) (Lindbo, 2007) were
produced by infection of N. benthamiana plants and by applying
a TMV purification protocol described previously (Niehl et al.,
2015).
Oligonucleotides and plasmids
All oligonucleotide primers are summarized in Table S4. An
agroinfection-compatible infectious TMV-GFP clone [(pJL24
(Lindbo, 2007)] was used as a template for the in vitro production
of TMV- and GFP-specific dsRNAs, as donor for a viral genome
Figure 5 Effect of local dsRNA treatment by spraying or mechanical inoculation on the local and systemic spread of TMV-GFP in infected N. benthamiana
plants. The virus-inoculated leaves were cotreated with in vivo-produced and purified dsRNArep-MP or dsRNAphi6 by either spraying or mechanical
inoculation, as indicated. The virus-inoculated leaves of control plants were either not treated (spraying control indicated with dash) or mechanically
inoculated with either H2O or in vitro-produced dsRNA
GFP4 (control for mechanical treatment). (a) Virus-inoculated leaves at 7 dpi. Four plants per
treatment are shown. Photographs were taken under UV light. Some plants were also part of the time-course experiment shown in Figure S3 (0-day time
point). (b) Quantitative analysis of the relative sizes of the infected leaf areas per condition. The total GFP fluorescent area measured for all the leaves was
set to 100%, and the distribution of the fluorescence between the conditions was quantified from the image shown in (a). Similar quantitative analysis was
also performed at 9 dpi and 14 dpi. The columns show the mean value and standard deviation for these three individual measurements. (c) Infection in the
systemic, nontreated leaves of same plants as in (a) at 9 dpi. (d) Quantitative analysis of the relative sizes of the infected GFP fluorescent leaf areas per
condition seen in (c).
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fragment (rep-MP) described below, as well as for initial infection
of N. benthamiana plants to produce virion particles for subse-
quent infection experiments. Plasmid pYY00 (Haseloff et al.,
1997) was used as a template for in vitro production of GFP4-
specific dsRNAs. The phi6 in vivo dsRNA production system is
based on plasmids pMH4, pLM656 and pLM991, which contain
complementary DNA (cDNA) copies of the phi6 genome seg-
ments S, M and L, respectively, inserted into plasmid pT7T319U
under the T7 RNA polymerase promoter (Olkkonen et al., 1990;
Sarin et al., 2012; Sun et al., 2004). The gene 5 of the S-segment
in the Slys construct encoded by pMH4 contains three successive
stop codons preventing the expression of the phi6 lysis functions
(Sarin et al., 2012). pMH4 also harbours a T7 transcription
termination signal downstream the Slys-encoding sequence. The
L-segment encoded by plasmid pLM991 (Lkan) contains a
kanamycin resistance gene (nptII) (Sun et al., 2004) for antibiotic
selection.
The S-segment-specific dsRNA production vector pLD18 is a
derivative of plasmid pMH4 and was generated by replacing the
SalI–KspI fragment of the S-segment-specific cDNA with a 441-nt
long SalI–KspI fragment containing a multiple cloning site (MCS)
from plasmid pPS9(+). pPS9(+) is a derivative of pPS9 (Aalto et al.,
2007), in which the egfp gene-containing EagI-PstI fragment was
replaced with a 98-nt long MCS sequence constructed by
annealing two complementary DNA oligonucleotides and
digested with EagI and PstI. The M-segment-specific vector
pMS1 was obtained from pLM656 by replacing the AflII–PstI
fragment of the M-segment in pLM656 with a 98-nt long MCS
with complementary cohesive ends. The MCS sequences were
constructed by annealing two complementary DNA oligonu-
cleotides. The dsRNA production vector pMS2 was obtained from
pMS1 by introducing the termination signal sequence for T7
polymerase [TATCTGTTGTTTGTCG (Sohn and Kang, 2005)]
downstream of the RNA replication signal of the remaining M-
segment cDNA using PCR. Fragments of the TMV-GFP genome
[nucleotides 2850–5460 (2611 nts) and 1921–5460 (3540 nts)]
encompassing parts of the replicase and movement protein (MP)
sequences (rep-MP) were cleaved using NdeI and ApaI, and NheI
and ApaI restriction sites, respectively, and were inserted into the
NdeI–ApaI and NheI–ApaI sites within the MCS of pLD18 and
pMS2 to produce plasmids pLD18-5 rep-MP and pMS2-9 rep-MP
(Table S3), respectively.





, dsRNAGFPv, dsRNAGFP4 and dsRNAk were
produced in in vitro using the Replikator RNAi Kit (Finnzymes,
Vantaa, Finland; Figure S1) according to the manufacturer’s
instructions. The DNA templates for dsRNA synthesis were
produced by PCR using gene-specific primers fused to T7 and
phi6 promoter sequences (Table S4) and purified using Nucle-
ospin PCR Gel and PCR cleanup columns (Macherey-Nagel)
before use. Following synthesis at 35 °C, the dsRNA preparations
were stored at 20 °C until use.
In vivo dsRNA production
For in vivo dsRNA production, electroporation-competent cells of
P. syringae LM2691 were produced as previously described (Sun
et al., 2004) and transformed with plasmid pLM991 together
with the S-, or S- and M-segment-specific constructs (Table S3).
After electroporation, the cells were recovered by incubation in
SOC solution (2% Bacto tryptone, 0.5% Bacto yeast extract,
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM
glucose) at +28 °C for 2 h, and the transformed cells were
selected by plating them on Luria plates containing kanamycin.
The plates were incubated at +28 °C for 2 days.
dsRNA was extracted from concentrated suspensions of
overnight grown liquid cultures using TRIzol-chloroform extrac-
tion, stepwise LiCl precipitation, followed by ammonium acetate
precipitation. The dsRNA pellet was solved in milliQ-purified
water and stored at -20 °C prior application to plant leaves. The
concentration of the purified in vivo-produced dsRNA was
measured using a NanoDrop 2000 UV-Vis spectrophotometer.
Inoculation of plants with virus and dsRNA
N. benthamiana plants were grown from seeds on soil in growth
chambers with 16-h/8-h light/dark periods at +22 °C/+18 °C.
Four- to seven-week-old N. benthamiana plants were treated
with dsRNA by dusting the leaves with celite and gently rubbing
the dusted leaves with approximately 5 lg dsRNA. The same
amount of dsRNA was applied for inoculation by spraying using
a clean spray bottle (perfume dispenser). Wetting the foliage
during watering was avoided during the duration of the experi-
ment. Viruses (20 ng of purified TMV-GFP virions) were applied by
rubbing the dsRNA-treated leaves in the presence of celite either
immediately or at later times after application of dsRNAs, as
indicated in the figure legends. Each dsRNA treatment experiment
was performed with three to four plants (replicates).
All inoculation experiments involved the use of the same virion
preparation to preserve stable inoculation conditions and the
same inoculum quality throughout experiments. Moreover, using
virions rather than in vitro-transcribed infectious TMV-GFP RNA as
inoculum, we aimed to mimic the conditions of natural virus
transmission. Indeed, TMV produces very stable virions that do
not depend on insect vectors for interplant transmission and are
transmitted mechanically. Although the efficiency of our mechan-
ical inoculation procedure is not known, the applied virion dosage
per leaf [ca. 3 9 108 particles, according to a molecular weight of
TMV (40 MDa, Santos and Castanho, 1996)] was considerably
higher than the number of virions that are transferred to the new
host plant by natural contact transmission. Usually, the latter is in
the range of single virions (between 1 and 4) despite that the
transmitting leaves may contain virus titers as high as 107–109
(Sacristan et al., 2011).
Imaging analysis of plants
Nicotiana benthamiana plants were photographed with a Nikon
D80 camera and 60-mm lens between 7 and 14 days postinoc-
ulation (dpi), as indicated in the text. For image acquisition, the
camera was fixed on a stand in a dark room, and the plants were
illuminated using a hand-held UVP Blak-Ray B-100 ultraviolet (UV)
lamp. Images were acquired in automatic mode. For imaging of
inoculated leaves, the leaves were detached from the plant and
flattened (if necessary) by covering them with a glass plate before
photographs were taken.
Quantification of TMV spread and dsRNA vaccination
effects
TMV spread within inoculated plants (data in Tables S1 and S2)
was quantified by analysis of the GFP-tagged areas of infection
using ImageJ image analysis software (https://imagej.nih.gov/ij/).
Using the threshold function of this software, the total area of the
green fluorescence in leaves or whole plants was measured and
the area in pixels calculated. Mean values and standard deviations
(SD) were calculated for each condition and each experiment.
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Unpaired t-tests were performed where applicable to test the
significance of observations between different samples.
For the analysis of TMV spread in time-course experiments after
mechanical and spray inoculation of in vivo- or in vitro-produced
dsRNA (Figures 5 and S3), photographs of all individual plants
belonging to an experiment were assembled so that all plant
replicates were aligned vertically and all conditions aligned
horizontally. The assembled image showing all these plant
samples together was thresholded for GFP fluorescence. The
green pixel intensity values measured in the vertically aligned
replicates for each condition were plotted along the horizontal
axis and resulted in green pixel intensity curves, each representing
the specific GFP fluorescence values across the four biological
replicates for each condition. The area below the curve for each
specific condition was integrated and taken as quantitative value
for the relative (%) total GFP fluorescence in the replicate plant
samples of the specific treatment (total GFP fluorescence in the
whole image = 100%).
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